EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

BioMarin Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

1 of 3
Summary
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes BioMarin Pharmaceutical, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BioMarin Pharmaceutical, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Key Findings
BioMarin Pharmaceutical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BioMarin Pharmaceutical, Inc. since January 2007.

Synopsis
- Provides intelligence on BioMarin Pharmaceutical, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by BioMarin Pharmaceutical, Inc. and its subsidiaries since 2007.

- Information about key financial and legal advisors for BioMarin Pharmaceutical, Inc.'s financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons To Buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about BioMarin Pharmaceutical, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors’ business structure and growth strategies.

Key Highlights
This report includes BioMarin Pharmaceutical, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BioMarin Pharmaceutical, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
Mergers and Acquisitions – Overview
Mergers and Acquisitions – Deal reports
CORPORATE VENTURING
Corporate Venturing – Overview
Corporate Venturing – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
CAPITAL RAISING
Capital Raising – Overview
Capital Raising – Deal reports

APPENDIX
About the Author Financial Deals Database
Deal Definition and Methodology
About the Author

List of Tables

BioMarin Pharmaceutical activity by deal type – volume (2012 -YTD2016)
BioMarin Pharmaceutical M&A average deal size – value ($m) (2012 -YTD2016)
BioMarin Pharmaceutical legal advisor ranking by value ($m)
BioMarin Pharmaceutical financial advisor ranking by value ($m)
Top Deals(2012 -YTD2016)
BioMarin Pharmaceutical targets and partners (2012 -YTD2016)
BioMarin Pharmaceutical M&A volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical M&A activity by geography (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing by geography (2012-YTD2016)
BioMarin Pharmaceutical partnership volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical partnership trend by key deal type (2012-YTD2016)
BioMarin Pharmaceutical capital raising volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical capital raising by deal type (2012-YTD2016)

List of Figures

BioMarin Pharmaceutical activity by deal type - volume (2012-YTD2016)
BioMarin Pharmaceutical M&A average deal size - value ($m)
BioMarin Pharmaceutical M&A volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical M&A activity by geography (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical corporate venturing by geography (2012-YTD2016)
BioMarin Pharmaceutical partnership volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical partnership trend by key deal type (2012-YTD2016)
BioMarin Pharmaceutical capital raising volume and value trend (2012-YTD2016)
BioMarin Pharmaceutical capital raising by deal type (2012-YTD2016)
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll